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BACKGROUND: Many papers have focused on the
importance of granulocytes in the process of reper-
fusion and ischemia. Most of the clinical studies
measured several parameters of this process during
and after coronary angiography, without taking into
account the effect of the radiographic contrast media
(RCM) used during this procedure.
Materials and methods: We performed a randomized
patient study (n/37) to evaluate the effect of ionic
and non-ionic RCM on granulocyte adhesion during
coronary angiography. We also evaluated the influ-
ence of the ionicity and osmolarity of the different
substances on granulocyte adhesion molecules in in
vitro experiments.
Results: The osmolarity of patient serum samples
increased from 3029 /1 to 3099 /1 mOsm/kg (p B/0.05)
after infusion of RCM. The CD11b expression in the
samples of the non-ionic RCM treated group in-
creased from 2219 /21 MFI to 3779 /30 MFI (p B/0.05)
measured as the absolute mean fluorescence inten-
sity (MFI), yet did not alter significantly in the ionic
RCM group. In contrast, the in vitro experiments
showed a reduction of the CD11b expression from
3609 /70 MFI to 1499 /30 MFI (p B/0.05) in the ionic
RCM group.
Conclusions: The upregulation of adhesion mole-
cules was significantly reduced in vivo with ionic
RCM, while ionic substances caused opposite effects
in vitro. This effect should be taken into account
when performing leukocyte functional analysis of
samples taken during angiography.
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Introduction
Leukocyte activation has been shown to play an
important role in different inflammatory processes.
Moreover, activation of leukocytes has been detected
in processes not only characterized or accompanied
by inflammation; for example, transplantation med-
icine,
1 shock
24 and ischemia/reperfusion
processes.
59
One of the most studied mechanisms of leukocyte
activation is adhesion. Indeed, in order to migrate
into tissue, inflammatory cells need to adhere to the
vessel wall. This process is linked to an upregulation
of adhesion molecules on both leukocytes and the
endothelium.
1012
Some studies attempted to analyze whether altered
expression of adhesion molecules is detected during
ischemia/reperfusion: for instance, in patients sub-
mitted to a coronary angiography and percutaneous
transluminal coronary angiography.
1315 Increased
expression of adhesion molecules on leukocytes
has been detected in ischemia/reperfusion.
Recently, scientists have become aware of the
influence of medication on the activation of leuko-
cytes. Moreover some radiographic contrast media
(RCM), which are injected in patients, are known
modulators of leukocyte function.
16 However, the
influence on the expression of adhesion molecules
has not been previously reported. Therefore, we
studied the effects of RCM, both assayed in vitro and
in vivo, on the upregulation of granulocyte/adhe-
sion and monocyte/adhesion complexes. We also
attempted to discriminate whether these effects were
attributable to either RCM ionicity or RCM osmolarity,
two characteristics used to classify these agents in
four arbitrary groups (Table 1).
Materials and methods
Patient inclusion
The inclusion criteria and study protocol were
approved by the ethical committee of the University
Hospital of Antwerp. Patients with stable angina,
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269scheduled for a coronary angiography, were consid-
ered eligible for inclusion in the study. Patients were
only included after informed consent.
Patients were excluded if (i) any sign of inflamma-
tion was present (leukocytosis, recent anamnesis of
infection, malignancy, etc.), (ii) anti-inflammatory
drugs (steroid or non-steroid) were taken on a
regular basis, or (iii) the leukocyte count was above
10
4 cells/mm
3 or if a granulocyte percentage above
75% was found upon analysis.
After inclusion, patients were treated at random
with ioxaglate (Hexabrix†; Guerbet Codali, Brussels,
Belgium) or iopromide (Ultravist†; Schering, Die-
gem, Belgium). In order to avoid interpretation bias,
the used RCM was unknown for the cardiologist.
Healthy volunteers
Several volunteers from the department of biochem-
istry of the University of Antwerp donated blood for
the in vitro experiments. The blood samples were
checked for leukocyte number and differentiation.
Volunteers were excluded according to the same
criteria as the patient population.
Catheterization technique
Cardiac catheterization was performed using the
Seldinger technique. All patients received a 6 Fr
arterial sheath in the left femoral artery. All samples
were obtained through the arterial sheath. Heparin
(5000 IU) was administered at the beginning of the
procedure.
Blood sample collection
Samples were collected using the Vacutainer† tech-
nique in 3 ml of ethylenediamine tetraacetic acid
(EDTA tubes) (Vacutainer†; Beckton Dickinson, Ply-
mouth, UK) and immediately analyzed. Blood sam-
ples were collected before angiography (at baseline)
and 5 min after the procedure was completed.
Eleven patients agreed to a third sample collection
taken 60 min after completion of the angiography.
The latter samples were used to measure the
osmolarity and leukocyte activation over a 1-h time
course. The samples were analyzed for the mem-
brane density of the leukocyte adhesion complex and
for serum osmolarity.
In vitro techniques
Leukocyte adhesion receptor labeling
For a rapid and efficient evaluation of the blood
samples, we used the staining procedure described
by Macey et al.
17 Briefly, whole blood (25 ml) was
incubated in the dark room, with 25 mlo f2/10
5 M
liquid dye solution 751 (LDS 751; Exciton, Dayton,
Ohio, USA) at 48C for 15 min. Subsequently the
samples were incubated and labeled with 10 mlo f
phyco-erythrine-conjugated anti-CD11b antibody
(CD11b-PE) (Beckton and Dickinson, Aalst, Belgium)
and fluoresceine-isothiocyanate-conjugated anti-
CD14 antibody (CD14-FITC) (Beckton and Dickin-
son). Incubation was performed at room temperature
for 10 min. Finally, RPMI-1640 medium (Gibco BRL,
Merelbeke, Belgium) buffered with 25 mM of HEPES
(Sigma, Bornem, Belgium) was added to a final
volume of 500 ml and analyzed on a flow cytometer
(FACScan; Beckton Dickinson). CD11b expression,
quantified as the mean fluorescence intensity, was
measured on granulocytes and monocytes, discrimi-
nated by scatter profile and CD14 expression.
Serum osmolarity measurement
Osmolaritiesweremeasured usinganautomated osm-
ometer (Cryomatic†, Model 3C2; Advanced Instru-
ments Inc., Needham Heights, Massachusetts, USA).
In vitro activation assay
Blood samples were collected from healthy volun-
teers (n/5). The samples were incubated with the
two types of RCM used in the catheterization unit of
the University Hospital: ioxaglate (HEXABRIX†;
Guerbet Codali) and iopromide (ULTRAVIST†; Scher-
ing).
After injection in patients, RCM dilutions were
estimated during the patient trial, and physiologically
acceptable dilutions (290, 310, 330 and 350 mOsm/
kg) were tested.
As RCM may have both ionic and osmotic proper-
ties, we supplemented phosphate-buffered saline
(PBS) solutions (Dulbecco’s Phosphate Buffered
Saline; Gibco BRL) with either saline or sucrose.
Saline solutions have osmotic and highly ionic
properties, whereas sucrose is a non-ionic com-
pound. We used both solutions in order to prepare
solvents with the same range of osmolarities as RCM.
Glucose (G), saline (S), ioxaglate (IX) and iopromide
(IP) were tested in the following osmolarities: 290,
310, 330 and 350 mOsm/kg. The Blank PBS was
tested in 280 mOsm/kg.
Blood samples of healthy volunteers were col-
lected in 4 ml EDTA tubes (Vacutainer†; Beckton
Table 1. Classiﬁcation of RCM
Low osmolarity High osmolarity
Non-ionic Ioversol
Iopromide
Iohexol
Iomeprol
Ionic Ioxaglate Ioxitalamate
Diatrizoate
Overview of the classification of RCM. The classification is based on
ionic and osmolar properties.
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aliquot was incubated with 4 ml of lysis buffer (155
mM NH4Cl, 10 mM KCO3, 0.1 mM Na2EDTA) for 5
min at room temperature.
Subsequently the samples were centrifuged for 15
min at 400 g. The supernatant was discarded and the
cell pellet was resuspended in either PBS or one of
the osmotic solutions. The incubation with the
osmotic solutions was maintained at 378C during 20
min, an incubation time that induced maximal
granulocyte activation as shown in preliminary ex-
periments (data not shown).
The cell suspension was incubated with 10 mlo f
CD11b-PE and CD14-FITC during 15 min, after which
the excess of non-ligated antibody was removed by
centrifugation. After resuspension in 500 ml PBS, flow
cytometric analysis for adhesion molecules was
performed.
Statistical analysis
Statview† software (version 5.0; SAS, Cary, North
Carolina, USA) was used for all statistical calculations.
Corrections for non-parametric analysis were per-
formed (i.e. Mann/Whitney, Kruskal/Wallis and
Spearman rank correlation analysis).
Whenever mean values and their range are men-
tioned, we used the standard error of the mean.
Results
Patient study
A total of 37 patients was included in the study. The
population consisted of 19 male subjects (age 61.19 /
8.5 years) and 18 female subjects (age 66.89 /11.5
years). Mean fluorescence signals at baseline showed
no difference between the ioxaglate-treated and the
iopromide-treated patients (Mann/Whitney p/0.72)
(Fig. 1).
Analysis of the samples revealed a significant
increase in CD11b intensity as well as osmolarity
after 5 min. A subpopulation of 21 patients agreed to
donate a third sample collected 60 min after injection
of RCM. The results are presented in Fig. 1. Iopro-
mide significantly elevated the CD11b-receptor den-
sity in the granulocyte population, 5 min after
administration (pB/0.001). This effect disappeared
after 60 min, and the fluorescence values returned to
baseline (p/0.81). The monocyte population
showed an analogous trend to elevate the CD11b-
receptor density (p/0.06). Monocyte activation also
seemed to persist for more than 60 min. Patients
treated with ioxaglate showed no significant differ-
ence in CD11b-receptor density over time.
The osmolarity of the samples was determined.
The measured baseline osmolarity was measured at
3029 /1 mOsm/kg. Samples taken 5 min after RCM
administration showed a significant (p/0.003) ele-
vation of the serum osmolarity (3099 /1 mOsm/kg).
The osmolarity of the samples at baseline and the
samples taken 60 min after RCM administration
(3049 /2 mOsm/kg) showed no statistical significant
difference. The results are presented in Fig. 2.
In vitro study
To validate the results of the clinical study, we
studied the effects of RCM on granulocytes and
monocytes in vitro. For convenience, the in vitro
experiments were limited to the two RCMs used in
our hospital. Blood samples were collected from
healthy volunteers (n/5).
As the maximal osmolarity in patients was esti-
mated to be 3099 /1 mOsm/kg, we used solutions
with an osmolarity varying between 290 and 350
mOsm/kg to study the activation of granulocytes in
osmotic media.
To properly evaluate the effect of the solutions we
normalized the mean fluorescence values. Granulo-
cytes can exhibit an elevated level of the initial
CD11b-receptor density. This form of elevated activ-
ity is denoted as ‘granulocyte priming’.
18 As the
maximal activity (degranulation or upregulation of
CD11b) of the granulocyte will not change, a primed
granulocyte will have an apparently decreased activ-
ity. We normalized the values in such a way that the
blank value (PBS without any additives) was corre-
lated with 0% activation and the maximal measured
value was expressed as 100% activation.
The results clearly showed a difference between
granulocyte and macrophage responses, as observed
in the clinical study (Fig. 3). CD11b-receptor density
on monocytes is relatively stable, regardless of the
degree of ionicity or osmolarity of the RCM. Granu-
locytes, on the contrary, seem to be more susceptible
to these factors.
To evaluate the effect of osmolarity on the activa-
tion of granulocytes and monocytes, we prepared a
concentration gradient of sucrose-enriched PBS solu-
tions. In order to rule out possible additive effects of
ionicity, a comparison was also made with analogous
solutions of PBS. Using a saline or sucrose gradient,
we could not establish any influence of either the
ionicity or osmolarity (Fig. 3), even at 350 mOsm/kg,
which is well above the measured osmolarity in vivo.
Next to the influence of ionicity and osmolarity we
also tested the RCMs. In this way we could evaluate
the substance-related effects, regardless of their ionic
and osmolar properties. Ioxaglate seems to exert a
significant downregulating effect on CD11b-receptors
at higher osmolarities; for example, at 330/350
mOsm/kg (hypothesis of no difference).
The effect is most prominent on the activity of
granulocytes. Using a Kruskal/Wallis analysis, we
Radiographic contrast media affect leukocyte adhesion
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ioxaglate and iopromide (Fig. 3). The effect can be
described as an inhibition of the upregulation of
CD11b-receptors at the cell membrane. Iopromide
does not show such an effect.
To correlate the effect of the ioxaglate concentra-
tion (in serum) to its inhibitory potential, a regression
analysis with Spearman rank correction was per-
formed (Fig. 4). This analysis produces a spearman
rho of 0.7 with an estimated r
2 value of 0.48. No other
significant correlations could be found.
Discussion
RCM are frequently used for both diagnostic proce-
dures and clinical research. Altering the X-ray absorp-
tion of tissues, vessels and cavities enables the
clinician to visualize anatomical structures in the
organism, which provides information about organ
mass and function, such as revascularization of the
coronary arteries.
However, many unwanted pharmacological effects
are observed after the use of RCM, ranging from
FIG. 1. Changes in CD11b levels on leukocytes after RCM infusion. The mean ﬂuorescence intensity (MFI) of anti-CD11b
antibody on granulocytes and monocytes during infusion of iopromide and ioxaglate. T0, sample taken before the initiation of
the procedure; T1, sample taken 5 min after infusion of RCM; T2, sample taken 60 min after the infusion of RCM. * Statistically
signiﬁcant differences (pB/0.05).
FIG. 2. Transient increase in serum osmolarity after iopromide infusion. T0, sample taken before the initiation of the
procedure; T1, sample taken 5 min after infusion of RCM; T2, sample taken 60 min after the infusion of RCM. * Statistically
signiﬁcant differences (pB/0.05).
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1921 to severe
anaphylactic reactions.
22,23 The latter is well studied
and many precautions can be taken to prevent
24 or
treat
25 its aftermath. RCMs affect different physiolo-
gical systems such as the coagulation and arachidonic
acid system and may interact with many human cells.
Several publications have covered the problem of
an elevated risk for thrombosis with non-ionic
substances.
2628 In vitro experiments have shown
that platelets more readily degranulate in the pre-
sence of non-ionic substances.
29
In our clinical study we observed an elevated
CD11b expression after iopromide injection. This
‘activating’ effect of iopromide, a member of the
non-ionic RCM group, has not yet been described in
the literature. An increased adhesion to nylon fibers
was described by Lang and Lang.
30
Yet ioxaglate does not affect the CD11b expression
in vivo, in contrast to the findings of Feldman et al.
31
The question remains of whether the ionicity or the
osmolarity of the substance is actually responsible for
this effect.
FIG. 3. ‘In vitro’ effect of osmolarity on CD11b expression. The effect of different solutions of iopromide, ioxaglate, sucrose
and saline, with increasing osmolarity, on granulocytes and monocytes. * Statistical signiﬁcant difference from zero (pB/
0.05). ** Signiﬁcant statistical (pB/0.05) ‘between group’ difference. CD11b-receptor density is expressed in% MFI, a value
normalized for blank and maximal stimulation.
FIG. 4. ‘In vitro’ effect of ioxaglate concentration on CD11b expression. Linear regression analysis for CD11b expression in%
MFI (normalized for blank and maximal value) and iodine concentration of ioxaglate (mg/ml). Linear regression was corrected
by Spearman rank calculation.
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neither osmolarity nor ionicity affected the activity
of the leukocytes in our experiment. Neither could
we observe a response to an elevation of the ionicity.
Sodium chloride could not evoke any response on
the leukocytes. Thus, ionicity alone cannot account
for the protective effects as described previously in
the literature.
32
From the results of the RCM in vitro experiments
we may conclude that ioxaglate exerts a down-
regulating effect on the adhesion molecules at higher
osmolarities. As neither osmolarity, nor ionicity is
responsible for this effect, the in vitro effect is
probably due to the ioxaglate concentration. This in
vitro effect is more evident on granulocytes than on
monocytes and has not yet been previously de-
scribed. Iopromide showed no significant effect on
the leukocytes whatsoever.
At first glance this seems rather contradictory with
regard to the in vivo experiment. This might well
mean that ioxaglate neutralizes a ‘catheterization-
associated’ activation, whereas the protective effect
of iopromide is too weak to exert any effect at all.
The results of this study clearly indicate that ionic
RCM may well inhibit leukocyte activation. The
question remains of whether the choice between
ionic and non-ionic RCM is indeed crucial. Several
authors implied that the choice between different
RCMs is not so important. Regardless of their ionic
and/or osmotic properties the overall clinical out-
come (in terms of major adverse cardiac events)
remains unchanged.
33,34 Other trials support the use
of ionic RCM as being more favorable.
35
Several other granulocyte functions are also influ-
enced after contact with RCM, but conflicting data
have been published. Following incubation of gran-
ulocyte with RCM, both a potentiation and an
inhibition of exocytosis (i.e. the release of proteases
by degranulation) has been reported.
36 Both inhibi-
tion
37 and increased chemotaxis
38 have also been
observed. Most papers indicated an inhibition of
phagocytosis.
39 In general, ionic media are more
inhibitory than non-ionic.
Many publications measured the membrane-asso-
ciated CD11b immediately after angiography or
percutaneous transluminal coronary angiography,
yet they do not specify the RCM used in their
protocol.
4042 The observed in vivo effects on
granulocyte functions have been described insignif-
icant and transient. However, they should be taken
into account when evaluating the early activation in
vivo during procedures of ischemia/reperfusion.
Caution is warranted for the interpretation of experi-
mental results measured within 30 min of RCM
administration.
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